ORTHOMIMETICS
Orthomimetics was founded in 2005 as a spin-out from the University of Cambridge and the Massachusetts Institute of Technology (MIT). Its products are based on a leading collagen biomaterials platform for the production of scaffolds for cartilage, meniscus, ligament and tendon repair. Orthomimetics’ flagship product, Chondromimetic™, is an off-the-shelf, resorbable implant for the minimally invasive repair of small osteochondral (cartilage and underlying bone) defects. The product has rec... eived European market approval (CE-Mark approval) and is close to entering the European market. Small osteochondral defects represent an important medical need that is currently not covered by TiGenix’ products. Chondromimetic™ forms an excellent fit with TiGenix’ lead product, ChondroCelect®, since both products target the same customer base in complementary indications.
ORTHOMIMETICS
Industry:
Biotechnology Manufacturing Medical
Founded:
2005-01-01
Address:
Dereham, Norfolk, United Kingdom
Country:
United Kingdom
Total Employee:
11+
Status:
Active
Total Funding:
5 M GBP
Similar Organizations
CRYOFIT
CRYOFIT is involved in the research, development, and production of biological glue used during surgical intervention and medical processes.
Current Employees Featured
Founder
Investors List
Sloane Robinson
Sloane Robinson investment in Series A - Orthomimetics
Schroders
Schroders investment in Series A - Orthomimetics
Oxford Capital Partners
Oxford Capital Partners investment in Series A - Orthomimetics
Goldman Sachs
Goldman Sachs investment in Series A - Orthomimetics
More informations about "Orthomimetics"
An invention to help repair damaged joints - University …
Sep 1, 2008 Orthomimetics has subsequently been awarded a further £2.1 million in grant funding to develop its technology and has made significant progress since its formation; it hopes to be selling its first product, …See details»
OrthoMimetics Company Profile 2024: Valuation, Investors
OrthoMimetics General Information Description. Operator of a medical technology company based in England, United Kingdom. The company specialises in the design, development, and …See details»
Andrew Lynn - Innovators Under 35
Organization Orthomimetics Region Global Share on Facebook; Share on Twitter; Share on Reddit; Share via email; Andrew Lynn wants to phase out metal joint replacements by coaxing the human body to rebuild damaged bone and …See details»
New ’‘tissue scaffolding’ reduces need for joint replacements
Jun 1, 2006 An exclusive licence has been signed by CMI and OrthoMimetics Ltd, the first technology company to emerge from the collaboration between the two universities, to …See details»
Next-generation medical implants - University of …
Sep 1, 2008 This has included the creation of spin-out companies; the most recent is Orthomimetics, an award-winning company and the first spin-out from the Cambridge-MIT Institute, which is developing products for regenerative …See details»
New tissue scaffold regrows cartilage and bone | MIT …
May 11, 2009 The technology has been licensed to Orthomimetics, a British company launched by one of Gibson's collaborators, Andrew Lynn of Cambridge University. The company recently received approval to start clinical trials in …See details»
OrthoMimetics - Products, Competitors, Financials, Employees ...
OrthoMimetics. Frequently Asked Questions (FAQ). When was OrthoMimetics founded? OrthoMimetics was founded in 2005. What is OrthoMimetics's latest funding round? …See details»
Orthomimetics - Funding, Financials, Valuation & Investors
Orthomimetics develops bio-material products such as Chondromimetic, which is used in treating underlying tissues and bone defects. Search Crunchbase. ... How much funding has this …See details»
Orthomimetics - Updates, News, Events, Signals & Triggers
Nov 30, 2009 Organization. Orthomimetics . Connect to CRM . Save . Summary. Financials. People. Signals & News. ... Discover more acquisitions . Funding Round • Dec 1, 2006. …See details»
TiGenix Acquires Orthomimetics - Mirus Capital Advisors
TiGenix announced that it has acquired Orthomimetics, a privately held medical technology company based in the United Kingdom. This acquisition further supports TiGenix’ growth strategy of becoming a leading player in the …See details»
TiGenix Seals $23.8M Share-Based Deal to Buy Orthomimetics
Nov 16, 2009 Belgium-based TiGenix is buying U.K. regenerative medicines company Orthomimetics in a share-based agreement that values the firm at $23.8 million on a debt- and …See details»
OrthoMimetics: Cambridge-MIT spin-out's technology aims to …
OrthoMimetics, the first technology spin-out to emerge from the Cambridge-MIT Institute, Cambridge, UK, has begun its search for initial funding. The company, which is developing …See details»
Andrew Lynn | MIT Technology Review
Orthomimetics. Andrew Lynn. ... His team focused on developing technologies for health care, inspired by a call from the World Health Organization (WHO) for new ways to deliver the …See details»
Biotech entrepreneur, educate thyself! | Bioentrepreneur - Nature
Dec 15, 2005 Cambridge-based OrthoMimetics competed in the finals of the East of England Development Agency's Running the Gauntlet competition. The prize was £1 million (US 1.8 …See details»
Orthomimetics - Crunchbase
Orthomimetics develops bio-material products such as Chondromimetic, which is used in treating underlying tissues and bone defects. ... Products. Resources. Pricing. Resources. Log In. …See details»
Orthomimetics - Contacts, Employees, Board Members, Advisors …
Organization. Orthomimetics . Connect to CRM . Save . Summary. Financials. People. Signals & News. Similar Companies. Highlights. Employee Profiles 2. About. Orthomimetics has 2 …See details»
Orthomimetics - University of Cambridge
Sep 1, 2008 Orthomimetics . Topic description and stories. Next-generation medical implants 01 Sep 2008. At the Cambridge Centre for Medical Materials, a highly interdisciplinary approach …See details»
TiGenix completes acquisition of Orthomimetics - BioWorld
Dec 3, 2009 Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation, business, financing, …See details»
Andrew Lynn - Chief Executive Officer - Crunchbase
Andrew Lynn is an entrepreneur and executive with a focus on early-stage life-sciences and technology opportunities. Andrew founded the regenerative medical device company …See details»